Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related DSW
Morgan Stanley Says Athletic Footwear Is 'The Trend To Play' During Earnings Season
Top 4 Mid-Cap Stocks In The Apparel Stores Industry With The Lowest PEG Ratio
DSW: Divergence Of Underlying Business And Stock Price Presents Opportunity (Seeking Alpha)
Related INFI
Stifel Talks 5 Biotech Stocks
Deutsche Sees Cancer Treatment Home Run At Infinity Pharmaceuticals

Body Central (NASDAQ: BODY) shares fell 25.33% to $11.94 in the pre-market trading. Body Central issued downbeat Q2 earnings forecast.

Infinity Pharmaceuticals (NASDAQ: INFI) dipped 22.55% to $10.75 in the pre-market session. Infinity Pharmaceuticals stopped mid-stage trials of saridegib in chondrosarcoma and myelofibrosis

DSW (NYSE: DSW) shares dropped 8.59% to $53.75 in pre-market trading. DSW reiterated its 2012 forecast. The company's board also authorized a new $100 million stock buyback program.

Steel Dynamics (NASDAQ: STLD) dipped 4.90% to $10.48 in the pre-market session. Steel Dynamics issued downbeat Q2 earnings forecast.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (DSW + BODY)

Get Benzinga's Newsletters